Literature DB >> 15466090

Features of invasive staphylococcal disease in neonates.

C Mary Healy1, Debra L Palazzi, Morven S Edwards, Judith R Campbell, Carol J Baker.   

Abstract

OBJECTIVE: Most clinical descriptions of invasive staphylococcal disease (ISD) in neonates date from before the mid-1980s, when neonatal viability and intensive care differed substantially from current standards. We aimed to describe the contemporary incidence, clinical features, and outcome of infants with ISD in a neonatal intensive care unit.
METHODS: A retrospective cohort study was conducted of infants who had ISD and were in the neonatal intensive care unit of the Woman's Hospital of Texas, Houston, from January 2000 to June 2002. Confirmed ISD was defined as clinical sepsis and Staphylococcus aureus (SA) isolated from > or =1 blood culture (BC) or a sterile body site excluding urine or coagulase-negative staphylococci (CoNS) isolated from > or =2 BC or from 1 BC and a sterile body site. Probable ISD was defined as CoNS isolated from 1 BC or a sterile body site for which clinical and laboratory data review by 3 infectious disease specialists indicated that antimicrobial treatment was appropriate. Confirmed and combined confirmed plus probable cases were analyzed.
RESULTS: A total of 149 episodes (83 confirmed [39 SA, 44 CoNS], 66 probable) in 137 infants (mean gestational age [GA]: 27.6 weeks [22.4-36.4]; mean birth weight: 981 g [350-2995]) were reviewed. Four (3%) infants had early-onset infection (2 SA, 2 CoNS). Median age at infection onset was similar (17 days SA; 18 days CoNS). Intravascular catheters (IVC) were in situ in a minority of infants with ISD episodes (38% SA, 43% CoNS). CoNS more than SA infections were associated with very low birth weight (<1500 g), lower GA, a history of more IVCs and concurrent total parenteral nutrition, but IVC and parenteral nutrition days were similar. By multivariate analysis correcting for birth weight and complications of prematurity, hypoxia at the time of sepsis evaluation was significantly associated with CoNS and hypotension with SA infections; other clinical features were similar. Methicillin-resistant SA caused 8% of SA infections. Among bacteremic infants, SA more frequently than CoNS involved > or =2 sites. Overall, SA had more focal complications (primarily bone and joint) than CoNS, resulting in a 2- to 3-fold higher SA-associated morbidity rate. Mortality directly attributable to either organism was similar (5% SA; 5% confirmed, 3% confirmed/probable CoNS).
CONCLUSION: CoNS ISD occurred in smaller, more premature infants than SA and was IVC associated in a minority of cases. Hypoxia and hypotension were the only presenting features that differentiated CoNS and SA. SA-associated morbidity was substantial, but SA infection carried no greater risk of death (5%) than CoNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466090     DOI: 10.1542/peds.2004-0043

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  The potential economic value of a Staphylococcus aureus vaccine for neonates.

Authors:  Bruce Y Lee; Paul J Ufberg; Rachel R Bailey; Ann E Wiringa; Kenneth J Smith; Andrew J Nowalk; Conor Higgins; Angela R Wateska; Robert R Muder
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

2.  Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.

Authors:  Jacob Kuint; Asher Barzilai; Gili Regev-Yochay; Ethan Rubinstein; Nati Keller; Ayala Maayan-Metzger
Journal:  Eur J Pediatr       Date:  2006-10-19       Impact factor: 3.183

3.  Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Authors:  Kevin M Watt; Christoph P Hornik; Stephen J Balevic; Gratias Mundakel; C Michael Cotten; Barrie Harper; Daniel K Benjamin; Ravinder Anand; Matthew Laughon; P Brian Smith; Michael Cohen-Wolkowiez
Journal:  Br J Clin Pharmacol       Date:  2019-03-06       Impact factor: 4.335

4.  Rapid typing of neonatal Staphylococcus epidermidis isolates using polymerase chain reaction for repeat regions in surface protein genes.

Authors:  A Ohlin; A Bäckman; B Söderquist; S Wingren; M Björkqvist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-11       Impact factor: 3.267

5.  Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants.

Authors:  Edmund V Capparelli; Barry T Bloom; Tom J Kueser; David G Oelberg; Ellen M Bifano; Robert D White; Robert L Schelonka; Stephen A Pearlman; Joseph Patti; Seth V Hetherington
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Coagulase-negative staphylococcal infections in the neonatal intensive care unit.

Authors:  Naomi Jean-Baptiste; Daniel K Benjamin; Michael Cohen-Wolkowiez; Vance G Fowler; Matthew Laughon; Reese H Clark; P Brian Smith
Journal:  Infect Control Hosp Epidemiol       Date:  2011-07       Impact factor: 3.254

7.  Very late onset infections in the neonatal intensive care unit.

Authors:  James L Wynn; Daniel K Benjamin; Daniel K Benjamin; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2011-09-15       Impact factor: 2.079

8.  Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus.

Authors:  Vilasack Thammavongsa; Sabine Rauch; Hwan Keun Kim; Dominique M Missiakas; Olaf Schneewind
Journal:  Vaccine       Date:  2014-12-06       Impact factor: 3.641

9.  Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Authors:  Kerry J Welsh; April N Abbott; Evan M Lewis; Jeanelle M Gardiner; Mark C Kruzel; Cole T Lewis; John F Mohr; Audrey Wanger; Lisa Y Armitige
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

10.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.